Fitzgerald Thomas A - Insider Non-Derivative Transactions at Transcode Therapeutics, Inc. (RNAZ) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Sep 28, 2023, Fitzgerald Thomas A's relationship to Transcode Therapeutics, Inc. (RNAZ) is Director,Officer (Chief Financial Officer), and currently has 56,318 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other RNAZ insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Fitzgerald Thomas A - Insider Non-Derivative Transactions of RNAZ Common Stock

Fitzgerald Thomas A - Insider Non-Derivative Transactions at RNAZ

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Sep 29, 2023	P -- (Common Stock)	49350	0.51	56318